EUVIMEDEUVIMED entdecken
Fallbericht

Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia

Elizabeth Abels, Jeremy W Jacobs iD, Daniel Prior, Laura C Willets, Nataliya Sostin, Christopher A Tormey iD, Thomas C Binns iD

Transfusion · 2023

DOI: 10.1111/trf.17548 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transfusion, 2023. Verfasst von Elizabeth Abels und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Erythroblastosis, Fetal, Anemia, Hemolytic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hemolytic disease of the fetus and newborn (HDFN) is characterized by destruction of fetal/neonatal red blood cells (RBCs) secondary to maternally derived antibodies, which are typically thought to be passively acquired via placental transfer. Few cases have examined the possibility of HDFN mediated by maternal antibodies passively transferred via breast milk.

Methods

We describe two cases of persistent HDFN in infants potentially mediated by passively acquired antibodies via maternal breast milk. We discuss supporting and refuting evidence that may account for this possibility and describe testing methodology illustrating how maternal alloantibodies can be detected in breast milk.

Results

In both cases, anti‐D antibodies were detected in maternal breast milk. One patient experienced a significant decrease in anti‐D plasma titer from 64 to 4 dilutions following 2 weeks of breastfeeding cessation. The other patient experienced a resolution of anemia without breastfeeding cessation.

Conclusion

There is a paucity of data regarding the lifespan of passively acquired RBC antibodies in neonatal circulation, with significant variation noted between passively acquired IgG based on studies utilizing intravenous immunoglobulin compared to studies of maternally‐acquired antiviral IgG antibodies. While our data do not definitively implicate passive transfer of alloantibodies in breast milk as a mediator of HDFN, they do illustrate the need for further investigation into the mechanisms and kinetics of passively acquired antibodies in neonatal circulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erythroblastosis, FetalAnemia, HemolyticInfant, NewbornHumansFemalePregnancyIsoantibodiesMilk, HumanPlacentaImmunoglobulin G

Stichwörter der Autor:innen

HDFNalloantibodiesalloimmunizationbreast milkbreastfeedinghemolysishemolytic disease of the fetus and newborn

Substanzen

IsoantibodiesImmunoglobulin G

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
  • Pediatric Clinical Nutrition, Yale New Haven Hospital, New Haven, Connecticut, USA.

ORCID-Profile: Jeremy W Jacobs, Christopher A Tormey, Thomas C Binns

Zitieren

APA

Abels, E., Jacobs, J. W., Prior, D., Willets, L. C., Sostin, N., Tormey, C. A., & Binns, T. C. (2023). Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia. Transfusion. https://doi.org/10.1111/trf.17548

Vancouver

Abels E, Jacobs JW, Prior D, Willets LC, Sostin N, Tormey CA, et al. Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia. Transfusion. 2023. doi:10.1111/trf.17548

BibTeX
@article{Abels2023,
  author = {Abels, Elizabeth and Jacobs, Jeremy W and Prior, Daniel and Willets, Laura C and Sostin, Nataliya and Tormey, Christopher A and Binns, Thomas C},
  title = {Passive transfer of alloantibodies through breast milk as a mediator of hemolytic anemia},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17548}
}
Kostenlos starten →